Canadian Association of Professionals in Regulatory Affairs | CAPRA

INTRODUCING
Regulated Affairs

Your Source for the Lastest News in Regulated Affairs in Canada!

CAPRA BENEFITS

The Canadian Association of Professionals in Regulatory Affairs (CAPRA) is an organization dedicated to providing its members with opportunities to enhance their professional development and maximize career opportunities. Whether you are a student, an entry-level associate or an experienced executive, a membership with CAPRA is a must.

We foster learning, networking and professional excellence of our members. We will build and strengthen relationships with governmental agencies, scientific experts and industry educators in order to create an affordable, professionally fulfilling and academically enriching environment for our members.

students joining CAPRA

WHY JOIN CAPRA AS A STUDENT?

For any full-time student in the Regulatory Programme qualifies to purchase a Student Membership.

BENEFITS

Save on event pricing!

  • NOC Magazine subscription
  • CAPRA Member Directory access
  • Volunteering  opportunities
  • Access to job listings and members-only content

Consultant Directory


Redstone Health Group Inc

Redstone Health Group Inc

Redstone Health Group is a strategic advisory group to the Pharmaceutical industry. We specialize in Canadian Federal drug regulatory requirements. We can help you find...
Innovia BioPharma

Innovia BioPharma

Partner of your success, Innovia-Biopharma supports you in the development of all your projects and your business. Our expertise of more than 20 years in Regulatory affairs,...
VG SOLUTIONS INC.

VG SOLUTIONS INC.

• Product drug DIN, NHP NPN applications, notifications and amendments, Medical device site and product licenses, Drug Establishment and Site Licensing • Liaison – Health...

ADVERTISE WITH CAPRA

Reach CAPRA members through the NOC (News of Course), or place an employment ad in our listings.

CAPRA BLOG


Rethinking Cost-Sharing: The Need for Health Insurance Reform in the U.S.
Rethinking Cost-Sharing: The Need for Health Insurance Reform in the U.S.
In the U.S., the system designed to protect Americans from the financial devastation of illness often ends up being the very source of that devastation. While it can be...
Value-Based Drug Pricing in Canada and its Limitations
Value-Based Drug Pricing in Canada and its Limitations
Drug pricing is a complex and controversial issue that often sparks debates among patients, pharmaceutical companies, and the government. Prices can vary significantly...
Addressing Underrepresentation in Clinical Trials: FDA's Diversity Action Plan
Addressing Underrepresentation in Clinical Trials: FDA's Diversity Action Plan
The U.S. Food and Drug Administration (FDA) released a new draft guidance in June 2024 to enhance the diversity of clinical trial participants. The guidance details the...